2017-09-07Zeitschriftenartikel
Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany
German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)
A live attenuated vaccine (Zostavax®)
against herpes zoster (HZ) and postherpetic
neuralgia (PHN) was licensed for
persons 50 years of age and older in 2006
and became available in Germany in September
2013. Based on ...